Cargando…

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder

Microarray analysis was used to investigate the lack of identified mammalian target of rapamycin (mTOR) pathway downstream genes to overcome cross-talk at non-muscle invasive high-grade (HG)-urothelial carcinoma (UC) of the bladder, gene expression patterns, gene ontology, and gene clustering by tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Subin, Chang, In Ho, Kim, Jin Wook, Whang, Young Mi, Kim, Ha Jeong, Hong, Soon Auck, Lee, Tae-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494333/ https://www.ncbi.nlm.nih.gov/pubmed/28665070 http://dx.doi.org/10.3346/jkms.2017.32.8.1327

Ejemplares similares

Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence
por: Kim, Soon-Ja, et al.
Publicado: (2014)

Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence
por: Kim, Soon-Ja, et al.
Publicado: (2014)

Letter to the Editor: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer
por: Li, Chenyu, et al.
Publicado: (2017)

The Author's Response: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer
por: Yoo, Chang-Hyuk
Publicado: (2017)

Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study
por: Park, Se Jun, et al.
Publicado: (2011)

Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013)

Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients
por: AFONSO, JULIETA, et al.
Publicado: (2014)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
por: Mucciardi, Giuseppe, et al.
Publicado: (2014)

Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
por: Kim, Hyera, et al.
Publicado: (2020)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
por: Madrakhimov, Sanjar Batirovich, et al.
Publicado: (2021)

Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
por: Jeong, Hyo-Soon, et al.
Publicado: (2011)

Role of mTOR Downstream Effector Signaling Molecules in Francisella Tularensis Internalization by Murine Macrophages
por: Edwards, Michael W., et al.
Publicado: (2013)

Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease
por: Fallone, Lucie, et al.
Publicado: (2023)

Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice
por: Jung, Mi-Ja, et al.
Publicado: (2016)

Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models
por: Choi, Se Young, et al.
Publicado: (2014)

The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022)

mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
por: Lee, Steven Hyun Seung, et al.
Publicado: (2022)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas
por: Koletsas, Nikolaos, et al.
Publicado: (2017)

mTOR-dependent signalling in Alzheimer's disease
por: Pei, Jin-Jing, et al.
Publicado: (2008)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder
por: Arslankoz, Sehbal, et al.
Publicado: (2017)

Prediction of high-grade ureteral urothelial carcinoma on CT urography
por: Sung Tae, Hwang, et al.
Publicado: (2017)

Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia
por: El Douaihy, Youssef, et al.
Publicado: (2016)

Akt (protein kinase B) isoform phosphorylation and signaling downstream of mTOR (mammalian target of rapamycin) in denervated atrophic and hypertrophic mouse skeletal muscle
por: Norrby, Marlene, et al.
Publicado: (2012)

Cytological Findings of the Micropapillary Variant of Urothelial Carcinoma: A Comparison with Typical High-Grade Urothelial Carcinoma
por: Kim, Kyu-Ho, et al.
Publicado: (2013)

Interaction of YAP1 and mTOR promotes bladder cancer progression
por: Xu, Mingxi, et al.
Publicado: (2019)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway
por: Janev, Aleksandar, et al.
Publicado: (2023)

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
por: Bowden, Michaela, et al.
Publicado: (2020)

Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview
por: Brambilla, Eleonora, et al.
Publicado: (2022)

Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report
por: Kamei, Maiko, et al.
Publicado: (2015)

mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
por: Wang, Zhuo, et al.
Publicado: (2014)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Effects of Stuffer DNA on the Suppression of Choroidal Neovascularization by a rAAV Expressing a mTOR-Inhibiting shRNA
por: Lee, Steven Hyun Seung, et al.
Publicado: (2019)

Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
por: Song, Yuxuan, et al.
Publicado: (2020)

Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia
por: Park, Jin-A, et al.
Publicado: (2017)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

Association of Membranous WNT-1 and Nuclear mTOR with Endometrial Cancer Grade
por: Pietrus, Milosz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7tkhdfhdiql3outo4sd8kffqlj